Therefore, as a tool to probe the relationship between IGF-1R and induction of replication-associated DNA damage, we examined responses to TMZ, a methylating agent used to treat glioblastoma multiforme and melanoma [16]. The gene discussed is IGF1R; the disease is melanoma.